VG-901

N/A

Report date: 2026/05/22 20:01:29

Base Information

Drug NameVG-901
Drug Alias NameVG-901
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionCyclic nucleotide-gated channel alpha-1 gene transference
TargetsCyclic nucleotide-gated channel alpha-1
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyEUMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesVeonGen Therapeutics GmbH
China Registration ClassN/A

Develop Information

Active CompaniesWuXi Advanced Therapies IncVeonGen Therapeutics GmbH
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A